Range
- - -
Vol / Avg.
8.3K/4.3M
Div / Yield
-
52 Wk
3.33 - 7.3
Mkt Cap
302.4M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.16
Shares
88.9M
Outstanding
88.9M
Total Float
88.1M
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. CG026806 (CG-806), its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL).

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.140-0.180 -0.0400
REV0
Q4 2020Est.ActualSurprise
EPS-0.140-0.170 -0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
APTOAptose Biosciences0.59%302.4M

Aptose Biosciences Frequently Asked Questions

Q

How do I buy Aptose Biosciences (APTO) stock?

A

You can purchase shares of Aptose Biosciences (NASDAQ: APTO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aptose Biosciences's (APTO) competitors?

A

There are no as such competitors for Aptose Biosciences.

Q

What is the target price for Aptose Biosciences (APTO) stock?

A

The latest price target for Aptose Biosciences (NASDAQ: APTO) was reported by Oppenheimer on March 24, 2021. The analyst firm set a price target for 9.00 expecting APTO to rise to within 12 months (a possible 164.71% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Aptose Biosciences (APTO)?

A

The stock price for Aptose Biosciences (NASDAQ: APTO) is $3.4 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Aptose Biosciences (APTO) pay a dividend?

A

There are no upcoming dividends for Aptose Biosciences.

Q

When is Aptose Biosciences (NASDAQ:APTO) reporting earnings?

A
Aptose Biosciences’s Q2 earnings are confirmed for after-market on August 3, 2021.
Q

Is Aptose Biosciences (APTO) going to split?

A

There is no upcoming split for Aptose Biosciences.

Q

What sector and industry does Aptose Biosciences (APTO) operate in?

A

Aptose Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.